Skip to main content
logo
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.8740
-0.0155 (-1.74%)
At close: Jul 11, 2025, 4:00 PM
0.8625
-0.0115 (-1.32%)
After-hours: Jul 11, 2025, 7:53 PM EDT

Biodexa Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.53M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 - - -
Dec 31, 2023 381.00K -318.00K -45.49%
Dec 31, 2022 699.00K 121.00K 20.93%
Dec 31, 2021 578.00K 235.00K 68.51%
Dec 31, 2020 343.00K -331.00K -49.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

BDRX News

More News